content top

Comparison of Clinical Characteristics in Myopic Traction Maculopathy with and Without MH

So Hyun Bae_SCIENTIFIC POSTER 2015 Purpose: To compare the clinical characteristics of myopic traction maculopathy (MTM) with and without macular hole (MH). Methods: This retrospective study included the patients with MTM who underwent vitrectomy. The eyes were subdivided into 2 groups based on the presence of MH. Clinical features were assessed including age, sex, axial length, visual acuity, posterior staphyloma, chorioretinal atrophy and...

Read More

Angiographic Features in Drug-induced Bilateral Angle Closure and Transient Myopia with Ciliochoroidal Effusion

Jae Pil Shin_SCIENTIFIC POSTER 2015_1 Purpose: To report angiographic findings of acute drug-induced angle closure and transient myopia with ciliochoroidal effusion. Methods: Slit lamp examination, intraocular pressure (IOP) measurement, ultrasound biomicroscopy (UBM), fluorescein angiography (FAG) and Indocyanine green angiography (ICGA) were performed in 4 patients who had acute drug-induced angle closure with ciliochoroidal...

Read More

Peripapillary Intrachoroidal Cavitation in Myopic Patient

Myopic patients more than -6 diopters may suffer from this newly recognized pathology previously termed peripapillary detachment in pathologic myopia. It affects 5 % of highly myopic eyes. Usually a yellowish round lesion can be observed inferiorly to the optic nerve during fundus examination. We described that complex forces like posterior expansion force, vitreous traction force, and vitreous fluid dynamics determine the size and shape of...

Read More

Choroidal Thickness in Highly Myopic Eyes

SCIENTIFIC POSTER_Mafalda Mota Purpose: Myopia (nearsightedness) is a prevalent disease. In the myopic eye the light rays focus anteriorly to the retina. High or pathologic myopia is defined as spherical equivalent refractive error greater than 6.00 diopters (D) or axial length greater than 26.5mm3. Patients with high myopia are at a greater risk of developing progressive retinal degeneration and other vision threatening pathology, such as...

Read More

Spontaneous Closure of a Myopic MH in a Vitrectomized Eye

We report on a 50 years-old female patient who underwent pars plana vitrectomy for a dropped nucleus and developed thereafter a myopic macular hole. The hole closed spontaneously during follow up. The patient had been referred to our clinic for a dropped nucleus on both eyes, and she underwent subsequent pars plana vitrectomy. We did not implant an intraocular lens because of the high myopic refraction. After surgery her visual acuity was...

Read More

Refractive Errors in High Myopic Eyes After Phacovitrectomy

SCIENTIFIC POSTER_Ji Wook Yang Purpose: To examine the postoperative refractive error in highly myopic eyes after phacovitrectomy. Setting: University clinic, Suwon, Kyounggi-do, South Korea. Methods: This retrospective study includes 101 eyes (21 high myopic, 80 non-high myopic eyes) of 101 patients who underwent successful phacovitrectomy (phacoemulsification, intraocular lens implantation and pars plana vitrectomy). The highly myopic...

Read More

Surgical Tricks for Beginners in Small Gauge Vitrectomy in Pathologic Myopia

SCIENTIFIC POSTER_So Hyun Bae Introduction: Pathologic myopia is characterized by excessive axial elongation with progressive degeneration of the posterior pole. It is often associated with posterior staphyloma or patchy chorioretinal atrophy at the posterior pole. In addition, it may lead to various complications requiring surgical management including myopic traction maculopathy and macular hole with or without retinal detachment....

Read More

Course 2014: Pathologic Myopia

Definition of pathologic myopia (syn. degenerative myopia) is not uniform. From the view­point of the clinician, axial myopia associated with structural changes of the posterior globe describes the condition most properly, as these alterations may threaten visual acuity. Refraction errors greater than 8 diopters are frequently associated with visual dysfunction. The prevalence of high myopia is apparently increasing, particularly in some...

Read More

Progression of Myopic Maculopathy After Treatment of Myopic CNV

The progression of myopic maculopathy may affect the long-term VA outcome of myopic CNV treatment. We evaluated the long-term progression of myopic maculopathy and functional outcome after treatment of myopic choroidal neovascularization (CNV) with photodynamic therapy (PDT) and/or intravitrealranibizumab (IVR). This was a retrospective study with a cross-sectional evaluation, including fifty-four eyes with a mean follow-up of 80.6 ± 28.0...

Read More

Myopic Choroidal Neovascularization

Pathological myopia is a common cause of visual impairment worldwide. Choroidal neovascularization (CNV) is its most threatening complication, often resulting in irreversible deterioration and loss of central vision. The precise pathogenesis of this disease remains unclear and several theories have been proposed. Improvements have been made in the diagnosis and characterization of myopic CNV over the years but there are no recognized...

Read More

Myopic Maculopathy – A Review

Pathological myopia (PM) is a leading cause of legal blindness in many developed countries, particularly in young people. It is usually defined as an axial length ≥ 26,5 mm and/or a refractive error of at least -6,00 D and characteristic posterior pole abnormalities. The prevalence of the disease shows a wide variation among different ethnic groups, being higher in Asian populations and lower in African and Pacific Island groups. PM is a...

Read More

Suprachoroidal Macular Buckling for Myopic Traction Maculopathy

Advantages: Myopic traction maculopathy (MTM), also known as myopic foveoschisis, describes the schisis-like thickening in the outer layers of highly myopic eyes with posterior staphyloma. Other findings may also include inner retinal fluid, foveal detachment, and lamellar or full-thickness macular holes followed by progressive retinal detachment. Suprachoroidal buckling (SCB) procedure is a new approach for treating MTM by creating...

Read More

Intravitreal Injection of Bevacizumab for Treatment of Subfoveal and Juxtafoveal Choroidal Neovascularization Associated with Pathologic Myopia: 2-Year Follow-Up

http://www.evrs.eu/medias/2010/congress/Non-Age-Related-Macular-Degeneration-Nor-Diabetes-Neovascularization.flv Barbara Parolini, Grazia Pertile (Verona, Italy) Advantages: The results of our study would advise an on-demand intravitreal injection of bevacizumab (IVB) for juxtafoveal and a monthly scheme for subfoveal myopic choroidal neovascularization (CNV). Methods: We retrospectively analyzed the charts of 45 patients with myopic CNV...

Read More

Long-Term Effects of Intravitreal Bevacizumab (Avastin) in the Treatment of Choroidal Neovascular Membranes Due to Pathologic Myopia

http://www.evrs.eu/medias/2010/congress/Non-Age-Related-Macular-Degeneration-Nor-Diabetes-Neovascularization.flv Andriy Sergienko, Lyubomyr Lytvynchuk (Kyiv, Ukraine) Advantages: Intravitreal bevacizumab (Avastin) is a new and safe surgical treatment for choroidal neovascularization due pathologic myopia (myopic CNV). It allows controlling CNV activity and does not lead to development of foveal chorioretinal atrophy. In some cases, it...

Read More

Primary Vitrectomy in the Treatment of Retinal Detachment in Highly Myopic Eyes with Axial Length Over 30mm

http://www.evrs.eu/medias/2006/congress/Primary-Vitrectomy-in-the-Treatment-of-Retinal-Detachment-in-Highly-Myopic-Eyes-with-Axial-Length-Over-30mm.swf http://www.evrs.eu/medias/2006/congress/Primary-Vitrectomy-in-the-Treatment-of-Retinal-Detachment-in-Highly-Myopic-Eyes-with-Axial-Length-Over-30mm.flv Gregoire Minoyan, MD (Nancy, France), Jean-Paul Berrod, MD (Nancy, France), Alexandre Guillaubey (Dijon, France), Isabelle Hubert, MD...

Read More

Safety and Efficacy of Intravitreal Bevacizumab for Subfoveal Choroidal Neovascularization in Pathologic Myopia

Myriam Lucia Hernandez-Rojas, MD (Mexico City, Jose Dalma- Weiszhausz, MD (MexicoCity, Mexico), Hugo Quiroz- Mercado, MD (Mexico City, Mexico), Jans Fromow-Guerra, MD, PhD (Mexico City, Mexico), Griselda Alvarez-Rivera, MD (Mexico City, Mexico), Maura Abraham-Marin, MD (Mexico City, Mexico), Adriana Solis-Vivanco, MD (Mexico City, Mexico), Elizabeth Reyna-Castelan, MD (Mexico City, Mexico), Jose Luis Guerrero-Naranjo,MD (Mexico City,...

Read More

Rhegmatogenous Retinal Detachment in Myopic Eyes after Lasik. Characteristics, Surgical Management and Functional Outcomes

http://www.evrs.eu/medias/2006/congress/Rhegmatogenous-Retinal-Detachment-in-Myopic-Eyes-after-Lasik.-Characteristics,-Surgical-Management-and-Functional-Outcomes.swf Anna Boixadera, MD (Barcelona, Spain), Vicente Martinez-Castillo, MD (Barcelona, Spain), Miguel Angel Zapata, MD (Barcelona, Spain), Jose Garcia-Arumi, MD (Barcelona, Spain) PURPOSE: To report the characteristics and surgical outcomes of rhegmatogenous retinal detachments...

Read More

Myopic Traction Maculopathy: A Slowly Progressive and Treatable Disease

http://www.evrs.eu/medias/2006/congress/Myopic-Traction-Maculopathy:-A-Slowly-Progressive-and-Treatable-Disease.swf Giacomo Panozzo, MD (Verona, Italy), Barbara Parolini, MD (Verona, Italy), Andrea Mercanti, MD (Verona, Italy) PURPOSE: Myopic Traction Maculopathy (MTM) is a recently discovered cause of visual impairment in high myopia, generated by the presence of anomalous vitreoretinal traction inside the staphyloma. Development, natural...

Read More

Posterior Retinal Detachment and Retinoschisis without a Macular Hole in Highly Myopic Eyes: Clinical Findings and Management

http://www.evrs.eu/medias/2006/congress/Posterior-Retinal-Detachment-and-Retinoschisis-without-a-Macular-Hole-in-Highly-Myopic-Eyes:-Clinical-Findings-and-Management.swf http://www.evrs.eu/medias/2006/congress/Posterior-Retinal-Detachment-and-Retinoschisis-without-a-Macular-Hole-in-Highly-Myopic-Eyes:-Clinical-Findings-and-%20Management.flv Hassan Mortada (Cairo, Egypt) PURPOSE: To describe the clinical and OCT findings as well as the...

Read More

ILM Removal in Idiopathic Macular Hole Surgery versus Myopic Macular Hole Surgery; Differences in Technique and Results

Khaled El-Rakhawy, MD Background: Myopic macular holes are different from idiopathic macular holes in their epidemiological characteristics, clinical presentation, surgical objectives and outcome. Some of the still ongoing controversies in the management of both conditions include the role of ILM removal as well as the technique used to achieve this, whether with or without staining. Methods: In vitrectomy for idiopathic macular holes,...

Read More

OCT in Active Choroidal Neovascularization Secondary to Pathologic Myopia

http://www.evrs.eu/medias/2005/congress/OCT-in-active-choroidal-neovascularization-secondary-to-pathologic-myopia.swf Murat Karacorlu, MD, Serra Arf Karacorlu, MD, Hakan Ozdemir, MD – Istanbul Retina Institute, Inc. Istanbul, Turkey Purpose: To evaluate the early optical coherence tomography (OCT) changes after photodynamic therapy (PDT) in patients with subfoveal choroidal neovascularization (CNV) secondary to pathologic...

Read More
content top